of Well-Being Therapeutics
Neswell Group specializes in the development of innovative cannabinoid based formulations (low THC) and advanced delivery methods, which will be integrated into a variety of daily-use wellness OTC products for pain and inflammation disorders.
Our team of experts brings
pharma-grade standards into the development of our projects, in order to deliver scientifically and clinically proven products into the market.
Our products will have IP protection, contain full-spectrum formulations, and will be based on varieties that are developed and cultivated on our farms.
To create advanced and clinically validated, anti- inflammatory, anti-microbial and analgesic formulations based on our full-spectrum model screening pipeline, that will be administrated with unique drug delivery methods.
Pioneering data-driven research towards novel medical cannabis solutions that will utilize the true potential of the Endocannabinoid System. Thus, positively impacting the well-being of people worldwide.
We have developed a strong validation process into the creation of our formulation and OTC products
Research of innovative ECS upregulation properties
Confirm delivery, bio-availability and upscaling
Screen via in-house
Validate by Clinical trial
Develop novel formulation and IP process
Approve products and manufacture
A multidisciplinary business leader with track record of managing companies in the tech world. MBA in Strategic management and Innovation. Vast knowledge and connections in the cannabis world.
Head of innovation and farms R&D
M.Sc. in Plant Science from the Hebrew University and has led a variety of R&D projects.
Jonathan has extensively advised as a scientific consultant for cannabis companies.
Dr. Ofra Benny, PH.D
Expert in Formulations and drug Delivery methods
A faculty member in the Hebrew University, with PH.D from Harvard Medical school. Has more than ten years of experience in biological/medical research and nanotechnology.
Noa Leibovitch, Ph.D
Scientific & strategic advisor
Noa brings more than 20 years of experience from Teva. Noa was a member of the Global R&D senior management team, lead Teva small molecule discovery and Branded Product Development and was a permanent member of the Teva-Lonza Board of Directors . Has vast experience in drug development in numerous indications.
Prof. Oded Shoseyov
Co-Founder & CSO
A leading researcher and a faculty member in the Hebrew University. Expert in plant molecular biology and Nano-biotechnology. A managing member in the ‘Israeli Cannabinoid Center’ and co-authored almost 50 patents.
A leading researcher with vast experience in drug development and delivery. Holds a Ph.d in biotechnology from THU and brings 7 years of experience from the , pharm industry in the field of research, innovation and product management.
Dr. Dudu Polak, MD
Expert in Immunology and
A faculty member in the Hebrew University and a leading researcher in the Hadassah Ein Kareem medical center. Has massive track record of successful projects.
Expert in Business Development and Financials Investments
Eran is a creative creator of cross - countries and continents investments opportunities. He has more than 25 years of experience in establishing and managing investments.
An operational expert in the cannabis industry, with deep knowledge in Israeli regulation. Expert in the licensing process of medical cannabis operations.
Has experience in the cultivation and production
Dana Yarden, MD
Dr. Yarden brings with her more than 10 years of experience in medical R&D, biotechnology, business development and clinical research. Formerly Dana served as the Clinical and BD Affairs Officer at Collplant and BioLineRx